WINNETKA, CA / ACCESSWIRE / August 20, 2015 /
Green Cures & Botanical Distribution Inc. (PINKSHEETS: GRCU)
("Green Cures"), a cannabis and industrial hemp products innovator,
announced today that Interim Chief Executive Officer, Romeo O. Cruz
issued a letter to the investment community and provided a
corporate update regarding the company's direction, and current
operations.
"I would first like to begin by thanking all of our loyal
consumers, business partners, shareholders and the investment
community for their continued support, which plays a significant
role in the future growth and success of our company.
"We have been aggressively working towards bringing in strategic
alliances, which we believe will help our company ascend to another
level. It has been my top priority to bring stable and positive
growth to Green Cures, along with, our shareholders, and I believe
we have made significant progress in doing just that. We are
aligning ourselves with industry professionals, who bring with them
years of experience in industries and areas required to strengthen
our foundation, as well as the knowledge needed for consistent
revenue generation. As acting CEO, we are at a very pivotal and
exciting moment of this rapidly growing industry, and I look
forward to a very profitable ride," stated Green Cures Interim CEO,
Romeo O. Cruz.
Products labeled Green Cures:
Currently, new and improved products labeled Green Cures are
being completed, and are in final labeling stages to be ready for
marketing and distribution. At the present time, brand development
and marketing experts are in the process of redesigning the
labeling of Green Cures' products. Management of the company
believes that the new design and labeling of Green Cures Hemp
Extract will facilitate the marketability, product placement, and
distribution of its hemp-derived products labeled Green Cures. The
company anticipates that the consumers will have the option to
purchase Green Cures Hemp Extract in different flavors and potency
levels such as, 100 mg, 200 mg, 500 mg, and 1500 mg of hemp extract
CBD.
Marketing & Distribution Program:
Green Cures & Botanical Distribution Inc., is pleased to
announce that it has teamed up with Monster Marketing Group Inc., a
subsidiary of New Generation Consumer Group Inc., another publicly
trading company, under symbol NGCG. Green Cures and Monster
Marketing Group are gearing up to launch numerous aggressive
marketing and promotional campaigns, and programs for selected
company products. Monster Marketing is a company dedicated to
providing marketing services to companies as well as product
concept development, and brand management. With the assistance of
Monster Marketing Group, Green Cures plans to expand brand
recognition of their unique products nationally, and in numerous
consumer markets.
Executive Team:
Management of the company is in the process of appointing
additional officers to its executive team and Board of Directors.
Upon the finalization of the new Board of Directors and complete
list of Officers, the company plans to announce publicly all names
of the management team. Green Cures plans to appoint industry
professionals to their executive team, who are seasoned in managing
marketing firms, experienced with publicly trading companies,
financing, as well as product development and implementation.
Quarterly Financial Report for the Period Ending June
30, 2015:
The Quarterly Financial Report and Disclosure for the period
ending June 30, 2015 is in the process of being completed; the
company anticipates that this report will be uploaded to the OTC
website on or before August 21, 2015.
Share Structure Information:
The company would like to inform to the public and the
investment community that there are no plans to increase the number
of authorized shares of the common stock of the company.
Additionally, the company does not plan to conduct any reverse
stock split, for the remaining of the year 2015. As of the date of
this announcement, the total number of authorized shares by the
company is 2.5 billion, while the current issued and outstanding
share count is an approximate of 1.91 billion. On July 1, 2015,
Green Cures & Botanical Distribution issued 100,000,000 shares
of the Company's restricted common stock to the controlling entity
of the Company, Green Cures Inc. These shares are being held by the
controlling entity, to provide Green Cures & Botanical
Distribution Inc., flexibility for future potential capital raising
transactions that may be needed for the Company's upcoming projects
or acquisition, when applicable.
Outstanding Debt:
On August 10, 2015, the company made one partial payment, to a
corresponding Government agency, for an outstanding tax liability,
which was previously announced on May 19, 2015. Effective July 28
2015, one hundred and fifteen thousand, two hundred and seventy
four dollars ($115,274) were removed from the company's
liabilities. The Company, at the request of the long term investor,
agreed to amend any unconverted note that was due and outstanding.
The number of Payment Shares issued to the long term investor upon
conversion of the outstanding notes was determined by dividing the
principal amount of the Notes, together with all accrued and unpaid
interest, by the closing bid price of the Borrower's common stock
on the business day immediately prior to the date of the
conversion.
In closing, the company will provide additional updates as they
become available.
About Green Cures & Botanical Distribution Inc.: Green Cures
& Botanical Distribution Inc. is a development stage company
that retails and wholesales hemp-infused nutritional, botanical,
sports, and body care products. The company is currently Web-based
and focuses on online retailing. Green Cures & Botanical
Distribution Inc. operates a diverse portfolio of products and
services within the botanical and cannabis industry, as permitted
by law. From concept to production and distribution, Green Cures
& Botanical Distribution Inc. is continuously creating and
introducing products that promote a healthy life style.
www.gcbdinc.com
FDA Statement:
The statements contained in this document have not been
evaluated or approved by the FDA. The products and statements
referenced in this document are not intended to diagnose, treat,
cure, or prevent any disease.
Forward-looking statement:
This press release may contain certain forward-looking
statements and information, as defined within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and is subject to the Safe Harbor
created by those sections. This material contains statements about
expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties.
Forward-looking statements are identified by wording such as
"scheduled (future sense)", "intend(s)", "plan(s)", "expect(s)",
"believe(s)" "will", "estimate(s)", "anticipate(s)", "expect(s)",
"may", "would", "could" or "should" or, in each case, the negative
thereof, other variations thereon, or comparable terminology that
implies anticipated future deliverables. The Company disclaims any
obligation or intention to update any forward-looking statement for
any reason.
Contact: info@gcbdinc.com
SOURCE: Green Cures & Botanical
Distribution Inc.
Green Cures and Botanica... (PK) (USOTC:GRCU)
Historical Stock Chart
From Mar 2025 to Apr 2025
Green Cures and Botanica... (PK) (USOTC:GRCU)
Historical Stock Chart
From Apr 2024 to Apr 2025
